Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor

Movement Disorders

Volumn 23, Issue 3, 2008, Pages 405-410

  Doepp, Florian ^a   Plotkin, Michail ^a   Siegel, Lara ^a   Kivi, Anatol ^a   Gruber, Doreen ^a   Lobsien, Elmar ^a   Kupsch, Andreas ^a   Schreiber, Stephan J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Essential tremor; FP CIT SPECT; Parkinson's disease; SN hyperechogenicity; Transcranial sonography

Indexed keywords

CONTRAST MEDIUM; DOPAMINE TRANSPORTER; IOFLUPANE I123; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; TROPANE DERIVATIVE;

ADULT; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC NERVE CELL; ECHOENCEPHALOGRAPHY; ESSENTIAL TREMOR; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; AGED; BRAIN; ECHOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

AGED; BRAIN; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 43049178497     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21861     Document Type: Article

References (28)

1. Deuschl G, Wenzelburger R, Raethjen J. Tremor. Curr Opin Neurol 2000;13:437-443.
2. Lance JW, Schwab RS, Peterson EA. Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain 1963;86:95-110.
3. 123I]ß-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998;105:1213-1228.
4. 123I]_FP_CIT study group. Mov Disord 2000;15:503-510.
5. 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study of 72 patients. J Neural Transm 2005; 112:677-692.
6. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners; K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-184.
7. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684-689.
8. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003;60:74-77.
9. Behnke S, Berg D, Naumann N, Becker G. Differentiation of Parkinson's disease and parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005;76:423-425.
10. Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple sytem atrophy, and progressive supranuclear palsy. Ann Neurol 1990;28:547-555.
11. Stockner H, Sojer M, Seppi K, et al. Midbrain sonography in patients with essential tremor. Mov Disord 2007;22:414-417.
12. 123I]-FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006;129:1188-1193.
13. Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria for essential tremor. A population perspective. Arch Neurol 1998;55:823-828.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
15. Chang L. A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.
16. Morton RJ, Guy MJ, Clauss R, Hinton PJ, Marshall CA, Clarke EA. Comparison of different methods of DatSCAN quantification. Nucl Med Commun 2005;26:1139-1146.
17. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109-1118.
18. Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R. Sonographic discrimination of corticobasal degeneration vs. progressive supranuclear palsy. Neurology 2004;63:504-509.
19. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53: 1026-1031.
20. Berg D, Roggendorf W, Schröder U, et al. Echogenicity of the substantia nigra - association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59:999-1005.
21. Ruprecht-Dörfler P, Berg D, Tucha O, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003;18:416-422.
22. Walter U, Klein C, Hilker R, Benecje R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004;19:1445-1449.
23. Schweitzer KJ, Hilker R, Walter U, Burghaus L, Berg D. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov Disord 2005;21: 94-98.
24. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography and SPECT. Mov Disord 2004;19:1196-1202.
25. Falm S and the Parkinson Study Group. Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol 2005;252 (Suppl 4):IV37-IV42.
26. Berg D, Merz B, Reiners K, Naumann N, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005;20:383-385.
27. Benamer HTS, Oertel WH, Patterson J, et al. Mov Disord 2003; 18:977-984.
28. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007; 13:67-76.